Newtown, PA – February 16, 2016 – Philadelphia resident Connor Galloway, VP, Rare Disease Center of Excellence of the award-winning Connexion Healthcare will be leading the Connexion Healthcare team in helping rare disease patients and families raise their voices at two events. First, he will join NORD and MassBIO at the State House in Boston, MA, on February 29th with members of Connexion’s newly formed Cambridge, MA office. Then he will represent co-sponsor Connexion Healthcare at the Rare Disease Day celebration in Harrisburg, PA, on March 16th. Mr Galloway is active in the Rare Disease community and is a founding member of the NORD Pennsylvania Rare Disease Day Planning Committee. He also currently co-chairs the Healthcare Provider Education committee for Global Genes, a national patient advocacy organization consisting of more than
500 rare disease groups and foundations.
Mr Galloway has been with Connexion Healthcare for more than 10 years. He has been responsible for the strategic planning and implementation of a variety of successful scientific communication and medical education campaigns and initiatives. As head of the Rare Disease Center of Excellence at Connexion, Mr. Galloway oversees a dedicated team composed of highly skilled medical, writing, program management, and event specialists who plan and prepare scientific communications based on an advanced knowledge of science, HCP education, patient communities, and the rare disease therapeutic area.
Connexion Healthcare, a full-service provider of medical and scientific communications, serves the world’s leading pharmaceutical, biotech, and medical device companies through its 2 Centers of Excellence — Oncology and Rare Disease. “We specialize in scientific communications in the rare disease space, and in addressing the unique challenges associated with effectively educating on rare diseases. Building awareness and educating healthcare professionals about rare diseases is at the core of Connexion Healthcare’s services. It is part of our mission and aligns perfectly with the goals of the both NORD and Global Genes. We look forward to contributing to advancing patient care,” said Connor Galloway.
For more than 30 years, NORD has been providing services for patients and their families, rare disease patient organizations, medical professionals, and those seeking to develop new diagnostics and treatments. The organization strives to support every member of the rare disease community by providing programs and services focused on improving the lives of individuals and families affected by rare diseases.
Global Genes™ began in 2009 as a grassroots movement with a few parents and advocates and is now supported globally. It is one of the leading non-profit rare disease patient advocacy organizations in the world that promotes the needs of the rare disease community. The Blue Denim Genes Ribbon™ is their unifying symbol of hope.